Management of methicillin-resistant Staphylococcus aureus bacteremia.
about
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciIn vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolatesInfectious diseases consultation lowers mortality from Staphylococcus aureus bacteremiaTrends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.Predictors of mortality in Staphylococcus aureus BacteremiaReasons, procedures, and outcomes in ventriculoatrial shunts: A single-center experienceIncidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus BacteremiaPlatelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.Advances in MRSA drug discovery: where are we and where do we need to be?Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms.Screening cardiac surgery patients for MRSA: an economic computer model.Treatment and recurrence management of staphylococcal infections: community-acquired MRSA.Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.Rifampin combination therapy for nonmycobacterial infections.Current management of bloodstream infections.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Appropriate use of echocardiography in managing Staphylococcus aureus bacteremia.Current trends in the management of cardiac implantable electronic device (CIED) infections.Closed incision management with negative pressure wound therapy.Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.Cost-effective modification of a commercial PCR assay for detection of methicillin-resistant or -susceptible Staphylococcus aureus in positive blood culturesMolecular typing of nosocomial Staphylococcus aureus strains associated to biofilm based on the coagulase and protein A gene polymorphisms.Hemoculture and Direct Sputum Detection of mecA-Mediated Methicillin-Resistant Staphylococcus aureus by Loop-Mediated Isothermal Amplification in Combination With a Lateral-Flow Dipstick.Treatment of methicillin-sensitive Staphylococcus aureus bacteremia secondary to septic phlebitis using dalbavancin.Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children.Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottlesThe first report in Brazil of severe infection caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.Antimicrobial Effects of Sulfonyl Derivative of 2(5H)-Furanone against Planktonic and Biofilm Associated Methicillin-Resistant and -Susceptible Staphylococcus aureus.Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
P2860
Q26853465-C182F0DB-6534-4906-9FB1-9587500DB874Q33876626-44FF667B-96DC-4601-8CB5-23D65309015BQ33895690-7D8C34AD-3005-4239-948F-803EECFC3213Q33961776-E14864E3-7D7D-4DAA-A17A-2A7A7220968CQ34157657-9F8A0C25-4C8E-4A73-B5CF-A444E11A5C39Q34529085-6E9326BF-73C9-4F86-8BC7-B79FE1A5033CQ35191417-34C11ACA-A09B-4641-9586-1525C9167AA2Q35940556-BB44F5F7-4294-4B2D-961D-61D5001AD23BQ36661093-D8F53C62-EF8C-45E9-994B-D7CDBBC464C9Q36729953-AD2AF467-D8AE-4F22-A670-990BA349F658Q36974434-B753F546-7395-4229-A599-D6F5317B1793Q37112508-560BAFAA-BE84-40C9-A2A2-A37238313B4EQ37119959-91F53E48-D687-4ACB-AE9A-3F16F0DBC989Q37147604-9B237823-7365-43AF-B648-8AFBA2E6A241Q37340558-3F4CBF5C-7DDB-4822-A492-0CCBB1966DB6Q37557686-E320BADD-5C0D-4276-8AB3-43E14433E093Q37672039-DCEC0655-461F-4EC3-8579-2268B2783FFDQ37768418-808BFD83-F370-486C-BB15-F2D2E94965A8Q37785546-465B29C3-08BF-469B-89C9-5C26C569013DQ38003495-ECAC8883-9253-429B-A2B3-35B418D907A8Q38022551-C17B7486-C128-419E-AE4E-13E21B901B48Q38206235-4B76F41C-AB83-4145-A253-22F3230AE2E5Q38793919-16E8FE38-907A-4364-BB00-43152BBEB0CBQ38926404-97B1E62B-CE7F-4A2D-842C-A8B93C110602Q39899568-AF1BD6A3-A253-434A-91BD-297FD2AB4366Q40368207-8244A471-AF4E-4572-8B65-03E3BAA55106Q40750245-41E21F51-F73B-4EA8-A49D-6468D9FE1482Q41104208-BC1A3F53-29EC-41FC-AF7C-F2F90F5A71F2Q41445957-7996670B-3E97-4F4E-A99C-ACBC144D6A75Q41511903-48130522-ED14-4F24-BE57-F0F98154D8B9Q42027484-F066E9F1-1EA6-4302-9073-1719DE161802Q42070457-9E0E6B64-9F05-4A12-ACB5-FDE583E64635Q44509330-1E945C2F-27A7-40E0-B04D-333CFF15A113Q46034505-560056AD-8759-4AB8-A09B-1F80B2564928Q47094873-4E9EDF09-4A4B-4754-83A6-E2924E5FEE62Q57763234-8C673115-E473-400F-ACE7-3683BF221F0D
P2860
Management of methicillin-resistant Staphylococcus aureus bacteremia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@en
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@nl
type
label
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@en
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@nl
prefLabel
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@en
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@nl
P2860
P356
P1476
Management of methicillin-resistant Staphylococcus aureus bacteremia.
@en
P2093
Sara E Cosgrove
P2860
P304
P356
10.1086/533595
P407
P478
46 Suppl 5
P577
2008-06-01T00:00:00Z